Article
CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations.
Mutation research. Reviews in mutation research - 1 Jan 2000
Gomari Mohammad Mahmoudi, Farsimadan Marziye, Rostami Neda, Mahmoudi Zahra, Fadaie Mahmood, Farhani Ibrahim, Tarighi Parastoo
Abstract excerpt
Among cell surface markers, CD44 is considered the main marker for identifying and isolating the cancer stem cells (CSCs) among other cells and has attracted significant attention in a variety of research areas. Many studies have shown the essential roles of CD44 in initiation, metastasis, and tumorigenesis in different types of cancer; however, the validity of CD44 as a therapeutic or diagnostic target has not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
